# Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network

> **NCT03164655** · PHASE2 · COMPLETED · sponsor: **UNICANCER** · enrollment: 20 (actual)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **DRUG:** Oxaliplatin, Cetuximab, Bevacizumab, Panitumumab, Irinotecan, Leucovorin, 5-Fluorouracil

## Key facts

- **NCT ID:** NCT03164655
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-25
- **Primary completion:** 2021-07-15
- **Final completion:** 2021-11-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164655, "Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03164655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*